Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product.
This report aims to provide a comprehensive presentation of the global market for Remicade Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Remicade Biosimilar. This report contains market size and forecasts of Remicade Biosimilar in global, including the following market information:
Global Remicade Biosimilar Market Revenue, 2018-2023, 20242035, ($ millions)
Global Remicade Biosimilar Market Sales, 2018-2023, 20242035, (L)
Global top five Remicade Biosimilar companies in 2022 (%)
The global Remicade Biosimilar market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
100mg/10ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Remicade Biosimilar include Synthon Pharmaceuticals, LG Life Sciences, Novartis (Sandoz), Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec Inc. and Genentech (Roche Group), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Remicade Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Remicade Biosimilar Market, by Type, 2018-2023, 20242035 ($ Millions) & (L)
Global Remicade Biosimilar Market Segment Percentages, by Type, 2022 (%)
100mg/10ml
500mg/50ml
Global Remicade Biosimilar Market, by Application, 2018-2023, 20242035 ($ Millions) & (L)
Global Remicade Biosimilar Market Segment Percentages, by Application, 2022 (%)
Blood Disorders
Oncology Diseases
Global Remicade Biosimilar Market, By Region and Country, 2018-2023, 20242035 ($ Millions) & (L)
Global Remicade Biosimilar Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Remicade Biosimilar revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Remicade Biosimilar revenues share in global market, 2022 (%)
Key companies Remicade Biosimilar sales in global market, 2018-2023 (Estimated), (L)
Key companies Remicade Biosimilar sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Fosun Pharmaceutical
Livzon Pharmaceutical
Anke Biotechnology
Hualan Biological Engineering
Walvax Biotechnology
Hisun Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Remicade Biosimilar, market overview.
Chapter 2: Global Remicade Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Remicade Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Remicade Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Remicade Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Remicade Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Remicade Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Remicade Biosimilar Overall Market Size
2.1 Global Remicade Biosimilar Market Size: 2022 VS 2035
2.2 Global Remicade Biosimilar Revenue, Prospects & Forecasts: 2018-2035
2.3 Global Remicade Biosimilar Sales: 2018-2035
3 Company Landscape
3.1 Top Remicade Biosimilar Players in Global Market
3.2 Top Global Remicade Biosimilar Companies Ranked by Revenue
3.3 Global Remicade Biosimilar Revenue by Companies
3.4 Global Remicade Biosimilar Sales by Companies
3.5 Global Remicade Biosimilar Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Remicade Biosimilar Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Remicade Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Remicade Biosimilar Players in Global Market
3.8.1 List of Global Tier 1 Remicade Biosimilar Companies
3.8.2 List of Global Tier 2 and Tier 3 Remicade Biosimilar Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Remicade Biosimilar Market Size Markets, 2022 & 2035
4.1.2 100mg/10ml
4.1.3 500mg/50ml
4.2 By Type - Global Remicade Biosimilar Revenue & Forecasts
4.2.1 By Type - Global Remicade Biosimilar Revenue, 2018-2023
4.2.2 By Type - Global Remicade Biosimilar Revenue, 2024-2035
4.2.3 By Type - Global Remicade Biosimilar Revenue Market Share, 2018-2035
4.3 By Type - Global Remicade Biosimilar Sales & Forecasts
4.3.1 By Type - Global Remicade Biosimilar Sales, 2018-2023
4.3.2 By Type - Global Remicade Biosimilar Sales, 2024-2035
4.3.3 By Type - Global Remicade Biosimilar Sales Market Share, 2018-2035
4.4 By Type - Global Remicade Biosimilar Price (Manufacturers Selling Prices), 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Remicade Biosimilar Market Size, 2022 & 2035
5.1.2 Blood Disorders
5.1.3 Oncology Diseases
5.2 By Application - Global Remicade Biosimilar Revenue & Forecasts
5.2.1 By Application - Global Remicade Biosimilar Revenue, 2018-2023
5.2.2 By Application - Global Remicade Biosimilar Revenue, 2024-2035
5.2.3 By Application - Global Remicade Biosimilar Revenue Market Share, 2018-2035
5.3 By Application - Global Remicade Biosimilar Sales & Forecasts
5.3.1 By Application - Global Remicade Biosimilar Sales, 2018-2023
5.3.2 By Application - Global Remicade Biosimilar Sales, 2024-2035
5.3.3 By Application - Global Remicade Biosimilar Sales Market Share, 2018-2035
5.4 By Application - Global Remicade Biosimilar Price (Manufacturers Selling Prices), 2018-2035
6 Sights by Region
6.1 By Region - Global Remicade Biosimilar Market Size, 2022 & 2035
6.2 By Region - Global Remicade Biosimilar Revenue & Forecasts
6.2.1 By Region - Global Remicade Biosimilar Revenue, 2018-2023
6.2.2 By Region - Global Remicade Biosimilar Revenue, 2024-2035
6.2.3 By Region - Global Remicade Biosimilar Revenue Market Share, 2018-2035
6.3 By Region - Global Remicade Biosimilar Sales & Forecasts
6.3.1 By Region - Global Remicade Biosimilar Sales, 2018-2023
6.3.2 By Region - Global Remicade Biosimilar Sales, 2024-2035
6.3.3 By Region - Global Remicade Biosimilar Sales Market Share, 2018-2035
6.4 North America
6.4.1 By Country - North America Remicade Biosimilar Revenue, 2018-2035
6.4.2 By Country - North America Remicade Biosimilar Sales, 2018-2035
6.4.3 US Remicade Biosimilar Market Size, 2018-2035
6.4.4 Canada Remicade Biosimilar Market Size, 2018-2035
6.4.5 Mexico Remicade Biosimilar Market Size, 2018-2035
6.5 Europe
6.5.1 By Country - Europe Remicade Biosimilar Revenue, 2018-2035
6.5.2 By Country - Europe Remicade Biosimilar Sales, 2018-2035
6.5.3 Germany Remicade Biosimilar Market Size, 2018-2035
6.5.4 France Remicade Biosimilar Market Size, 2018-2035
6.5.5 U.K. Remicade Biosimilar Market Size, 2018-2035
6.5.6 Italy Remicade Biosimilar Market Size, 2018-2035
6.5.7 Russia Remicade Biosimilar Market Size, 2018-2035
6.5.8 Nordic Countries Remicade Biosimilar Market Size, 2018-2035
6.5.9 Benelux Remicade Biosimilar Market Size, 2018-2035
6.6 Asia
6.6.1 By Region - Asia Remicade Biosimilar Revenue, 2018-2035
6.6.2 By Region - Asia Remicade Biosimilar Sales, 2018-2035
6.6.3 China Remicade Biosimilar Market Size, 2018-2035
6.6.4 Japan Remicade Biosimilar Market Size, 2018-2035
6.6.5 South Korea Remicade Biosimilar Market Size, 2018-2035
6.6.6 Southeast Asia Remicade Biosimilar Market Size, 2018-2035
6.6.7 India Remicade Biosimilar Market Size, 2018-2035
6.7 South America
6.7.1 By Country - South America Remicade Biosimilar Revenue, 2018-2035
6.7.2 By Country - South America Remicade Biosimilar Sales, 2018-2035
6.7.3 Brazil Remicade Biosimilar Market Size, 2018-2035
6.7.4 Argentina Remicade Biosimilar Market Size, 2018-2035
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Remicade Biosimilar Revenue, 2018-2035
6.8.2 By Country - Middle East & Africa Remicade Biosimilar Sales, 2018-2035
6.8.3 Turkey Remicade Biosimilar Market Size, 2018-2035
6.8.4 Israel Remicade Biosimilar Market Size, 2018-2035
6.8.5 Saudi Arabia Remicade Biosimilar Market Size, 2018-2035
6.8.6 UAE Remicade Biosimilar Market Size, 2018-2035
7 Manufacturers & Brands Profiles
7.1 Synthon Pharmaceuticals
7.1.1 Synthon Pharmaceuticals Company Summary
7.1.2 Synthon Pharmaceuticals Business Overview
7.1.3 Synthon Pharmaceuticals Remicade Biosimilar Major Product Offerings
7.1.4 Synthon Pharmaceuticals Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.1.5 Synthon Pharmaceuticals Key News & Latest Developments
7.2 LG Life Sciences
7.2.1 LG Life Sciences Company Summary
7.2.2 LG Life Sciences Business Overview
7.2.3 LG Life Sciences Remicade Biosimilar Major Product Offerings
7.2.4 LG Life Sciences Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.2.5 LG Life Sciences Key News & Latest Developments
7.3 Novartis (Sandoz)
7.3.1 Novartis (Sandoz) Company Summary
7.3.2 Novartis (Sandoz) Business Overview
7.3.3 Novartis (Sandoz) Remicade Biosimilar Major Product Offerings
7.3.4 Novartis (Sandoz) Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.3.5 Novartis (Sandoz) Key News & Latest Developments
7.4 Celltrion
7.4.1 Celltrion Company Summary
7.4.2 Celltrion Business Overview
7.4.3 Celltrion Remicade Biosimilar Major Product Offerings
7.4.4 Celltrion Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.4.5 Celltrion Key News & Latest Developments
7.5 Biocon
7.5.1 Biocon Company Summary
7.5.2 Biocon Business Overview
7.5.3 Biocon Remicade Biosimilar Major Product Offerings
7.5.4 Biocon Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.5.5 Biocon Key News & Latest Developments
7.6 Hospira
7.6.1 Hospira Company Summary
7.6.2 Hospira Business Overview
7.6.3 Hospira Remicade Biosimilar Major Product Offerings
7.6.4 Hospira Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.6.5 Hospira Key News & Latest Developments
7.7 Merck Serono (Merck Group)
7.7.1 Merck Serono (Merck Group) Company Summary
7.7.2 Merck Serono (Merck Group) Business Overview
7.7.3 Merck Serono (Merck Group) Remicade Biosimilar Major Product Offerings
7.7.4 Merck Serono (Merck Group) Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.7.5 Merck Serono (Merck Group) Key News & Latest Developments
7.8 Biogen idec Inc.
7.8.1 Biogen idec Inc. Company Summary
7.8.2 Biogen idec Inc. Business Overview
7.8.3 Biogen idec Inc. Remicade Biosimilar Major Product Offerings
7.8.4 Biogen idec Inc. Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.8.5 Biogen idec Inc. Key News & Latest Developments
7.9 Genentech (Roche Group)
7.9.1 Genentech (Roche Group) Company Summary
7.9.2 Genentech (Roche Group) Business Overview
7.9.3 Genentech (Roche Group) Remicade Biosimilar Major Product Offerings
7.9.4 Genentech (Roche Group) Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.9.5 Genentech (Roche Group) Key News & Latest Developments
7.10 Fosun Pharmaceutical
7.10.1 Fosun Pharmaceutical Company Summary
7.10.2 Fosun Pharmaceutical Business Overview
7.10.3 Fosun Pharmaceutical Remicade Biosimilar Major Product Offerings
7.10.4 Fosun Pharmaceutical Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.10.5 Fosun Pharmaceutical Key News & Latest Developments
7.11 Livzon Pharmaceutical
7.11.1 Livzon Pharmaceutical Company Summary
7.11.2 Livzon Pharmaceutical Remicade Biosimilar Business Overview
7.11.3 Livzon Pharmaceutical Remicade Biosimilar Major Product Offerings
7.11.4 Livzon Pharmaceutical Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.11.5 Livzon Pharmaceutical Key News & Latest Developments
7.12 Anke Biotechnology
7.12.1 Anke Biotechnology Company Summary
7.12.2 Anke Biotechnology Remicade Biosimilar Business Overview
7.12.3 Anke Biotechnology Remicade Biosimilar Major Product Offerings
7.12.4 Anke Biotechnology Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.12.5 Anke Biotechnology Key News & Latest Developments
7.13 Hualan Biological Engineering
7.13.1 Hualan Biological Engineering Company Summary
7.13.2 Hualan Biological Engineering Remicade Biosimilar Business Overview
7.13.3 Hualan Biological Engineering Remicade Biosimilar Major Product Offerings
7.13.4 Hualan Biological Engineering Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.13.5 Hualan Biological Engineering Key News & Latest Developments
7.14 Walvax Biotechnology
7.14.1 Walvax Biotechnology Company Summary
7.14.2 Walvax Biotechnology Business Overview
7.14.3 Walvax Biotechnology Remicade Biosimilar Major Product Offerings
7.14.4 Walvax Biotechnology Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.14.5 Walvax Biotechnology Key News & Latest Developments
7.15 Hisun Pharmaceutical
7.15.1 Hisun Pharmaceutical Company Summary
7.15.2 Hisun Pharmaceutical Business Overview
7.15.3 Hisun Pharmaceutical Remicade Biosimilar Major Product Offerings
7.15.4 Hisun Pharmaceutical Remicade Biosimilar Sales and Revenue in Global (2018-2023)
7.15.5 Hisun Pharmaceutical Key News & Latest Developments
8 Global Remicade Biosimilar Production Capacity, Analysis
8.1 Global Remicade Biosimilar Production Capacity, 2018-2035
8.2 Remicade Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Remicade Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Remicade Biosimilar Supply Chain Analysis
10.1 Remicade Biosimilar Industry Value Chain
10.2 Remicade Biosimilar Upstream Market
10.3 Remicade Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Remicade Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Remicade Biosimilar in Global Market
Table 2. Top Remicade Biosimilar Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Remicade Biosimilar Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Remicade Biosimilar Revenue Share by Companies, 2018-2023
Table 5. Global Remicade Biosimilar Sales by Companies, (L), 2018-2023
Table 6. Global Remicade Biosimilar Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Remicade Biosimilar Price (2018-2023) & (US$/Ml)
Table 8. Global Manufacturers Remicade Biosimilar Product Type
Table 9. List of Global Tier 1 Remicade Biosimilar Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Remicade Biosimilar Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Remicade Biosimilar Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Global Remicade Biosimilar Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Remicade Biosimilar Revenue (US$, Mn), 2024-2035
Table 14. By Type - Global Remicade Biosimilar Sales (L), 2018-2023
Table 15. By Type - Global Remicade Biosimilar Sales (L), 2024-2035
Table 16. By Application ? Global Remicade Biosimilar Revenue, (US$, Mn), 2022 & 2035
Table 17. By Application - Global Remicade Biosimilar Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Remicade Biosimilar Revenue (US$, Mn), 2024-2035
Table 19. By Application - Global Remicade Biosimilar Sales (L), 2018-2023
Table 20. By Application - Global Remicade Biosimilar Sales (L), 2024-2035
Table 21. By Region ? Global Remicade Biosimilar Revenue, (US$, Mn), 2022 VS 2035
Table 22. By Region - Global Remicade Biosimilar Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Remicade Biosimilar Revenue (US$, Mn), 2024-2035
Table 24. By Region - Global Remicade Biosimilar Sales (L), 2018-2023
Table 25. By Region - Global Remicade Biosimilar Sales (L), 2024-2035
Table 26. By Country - North America Remicade Biosimilar Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Remicade Biosimilar Revenue, (US$, Mn), 2024-2035
Table 28. By Country - North America Remicade Biosimilar Sales, (L), 2018-2023
Table 29. By Country - North America Remicade Biosimilar Sales, (L), 2024-2035
Table 30. By Country - Europe Remicade Biosimilar Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Remicade Biosimilar Revenue, (US$, Mn), 2024-2035
Table 32. By Country - Europe Remicade Biosimilar Sales, (L), 2018-2023
Table 33. By Country - Europe Remicade Biosimilar Sales, (L), 2024-2035
Table 34. By Region - Asia Remicade Biosimilar Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Remicade Biosimilar Revenue, (US$, Mn), 2024-2035
Table 36. By Region - Asia Remicade Biosimilar Sales, (L), 2018-2023
Table 37. By Region - Asia Remicade Biosimilar Sales, (L), 2024-2035
Table 38. By Country - South America Remicade Biosimilar Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Remicade Biosimilar Revenue, (US$, Mn), 2024-2035
Table 40. By Country - South America Remicade Biosimilar Sales, (L), 2018-2023
Table 41. By Country - South America Remicade Biosimilar Sales, (L), 2024-2035
Table 42. By Country - Middle East & Africa Remicade Biosimilar Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Remicade Biosimilar Revenue, (US$, Mn), 2024-2035
Table 44. By Country - Middle East & Africa Remicade Biosimilar Sales, (L), 2018-2023
Table 45. By Country - Middle East & Africa Remicade Biosimilar Sales, (L), 2024-2035
Table 46. Synthon Pharmaceuticals Company Summary
Table 47. Synthon Pharmaceuticals Remicade Biosimilar Product Offerings
Table 48. Synthon Pharmaceuticals Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 49. Synthon Pharmaceuticals Key News & Latest Developments
Table 50. LG Life Sciences Company Summary
Table 51. LG Life Sciences Remicade Biosimilar Product Offerings
Table 52. LG Life Sciences Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 53. LG Life Sciences Key News & Latest Developments
Table 54. Novartis (Sandoz) Company Summary
Table 55. Novartis (Sandoz) Remicade Biosimilar Product Offerings
Table 56. Novartis (Sandoz) Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 57. Novartis (Sandoz) Key News & Latest Developments
Table 58. Celltrion Company Summary
Table 59. Celltrion Remicade Biosimilar Product Offerings
Table 60. Celltrion Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 61. Celltrion Key News & Latest Developments
Table 62. Biocon Company Summary
Table 63. Biocon Remicade Biosimilar Product Offerings
Table 64. Biocon Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 65. Biocon Key News & Latest Developments
Table 66. Hospira Company Summary
Table 67. Hospira Remicade Biosimilar Product Offerings
Table 68. Hospira Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 69. Hospira Key News & Latest Developments
Table 70. Merck Serono (Merck Group) Company Summary
Table 71. Merck Serono (Merck Group) Remicade Biosimilar Product Offerings
Table 72. Merck Serono (Merck Group) Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 73. Merck Serono (Merck Group) Key News & Latest Developments
Table 74. Biogen idec Inc. Company Summary
Table 75. Biogen idec Inc. Remicade Biosimilar Product Offerings
Table 76. Biogen idec Inc. Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 77. Biogen idec Inc. Key News & Latest Developments
Table 78. Genentech (Roche Group) Company Summary
Table 79. Genentech (Roche Group) Remicade Biosimilar Product Offerings
Table 80. Genentech (Roche Group) Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 81. Genentech (Roche Group) Key News & Latest Developments
Table 82. Fosun Pharmaceutical Company Summary
Table 83. Fosun Pharmaceutical Remicade Biosimilar Product Offerings
Table 84. Fosun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 85. Fosun Pharmaceutical Key News & Latest Developments
Table 86. Livzon Pharmaceutical Company Summary
Table 87. Livzon Pharmaceutical Remicade Biosimilar Product Offerings
Table 88. Livzon Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 89. Livzon Pharmaceutical Key News & Latest Developments
Table 90. Anke Biotechnology Company Summary
Table 91. Anke Biotechnology Remicade Biosimilar Product Offerings
Table 92. Anke Biotechnology Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 93. Anke Biotechnology Key News & Latest Developments
Table 94. Hualan Biological Engineering Company Summary
Table 95. Hualan Biological Engineering Remicade Biosimilar Product Offerings
Table 96. Hualan Biological Engineering Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 97. Hualan Biological Engineering Key News & Latest Developments
Table 98. Walvax Biotechnology Company Summary
Table 99. Walvax Biotechnology Remicade Biosimilar Product Offerings
Table 100. Walvax Biotechnology Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 101. Walvax Biotechnology Key News & Latest Developments
Table 102. Hisun Pharmaceutical Company Summary
Table 103. Hisun Pharmaceutical Remicade Biosimilar Product Offerings
Table 104. Hisun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2018-2023)
Table 105. Hisun Pharmaceutical Key News & Latest Developments
Table 106. Remicade Biosimilar Production Capacity (L) of Key Manufacturers in Global Market, 2021-2023 (L)
Table 107. Global Remicade Biosimilar Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Remicade Biosimilar Production by Region, 2018-2023 (L)
Table 109. Global Remicade Biosimilar Production by Region, 2024-2035 (L)
Table 110. Remicade Biosimilar Market Opportunities & Trends in Global Market
Table 111. Remicade Biosimilar Market Drivers in Global Market
Table 112. Remicade Biosimilar Market Restraints in Global Market
Table 113. Remicade Biosimilar Raw Materials
Table 114. Remicade Biosimilar Raw Materials Suppliers in Global Market
Table 115. Typical Remicade Biosimilar Downstream
Table 116. Remicade Biosimilar Downstream Clients in Global Market
Table 117. Remicade Biosimilar Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Remicade Biosimilar Segment by Type in 2022
Figure 2. Remicade Biosimilar Segment by Application in 2022
Figure 3. Global Remicade Biosimilar Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Remicade Biosimilar Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Remicade Biosimilar Revenue, 2018-2035 (US$, Mn)
Figure 7. Remicade Biosimilar Sales in Global Market: 2018-2035 (L)
Figure 8. The Top 3 and 5 Players Market Share by Remicade Biosimilar Revenue in 2022
Figure 9. By Type - Global Remicade Biosimilar Revenue, (US$, Mn), 2022 & 2035
Figure 10. By Type - Global Remicade Biosimilar Revenue Market Share, 2018-2035
Figure 11. By Type - Global Remicade Biosimilar Sales Market Share, 2018-2035
Figure 12. By Type - Global Remicade Biosimilar Price (US$/Ml), 2018-2035
Figure 13. By Application - Global Remicade Biosimilar Revenue, (US$, Mn), 2022 & 2035
Figure 14. By Application - Global Remicade Biosimilar Revenue Market Share, 2018-2035
Figure 15. By Application - Global Remicade Biosimilar Sales Market Share, 2018-2035
Figure 16. By Application - Global Remicade Biosimilar Price (US$/Ml), 2018-2035
Figure 17. By Region - Global Remicade Biosimilar Revenue, (US$, Mn), 2022 & 2035
Figure 18. By Region - Global Remicade Biosimilar Revenue Market Share, 2018 VS 2022 VS 2035
Figure 19. By Region - Global Remicade Biosimilar Revenue Market Share, 2018-2035
Figure 20. By Region - Global Remicade Biosimilar Sales Market Share, 2018-2035
Figure 21. By Country - North America Remicade Biosimilar Revenue Market Share, 2018-2035
Figure 22. By Country - North America Remicade Biosimilar Sales Market Share, 2018-2035
Figure 23. US Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 24. Canada Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 25. Mexico Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 26. By Country - Europe Remicade Biosimilar Revenue Market Share, 2018-2035
Figure 27. By Country - Europe Remicade Biosimilar Sales Market Share, 2018-2035
Figure 28. Germany Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 29. France Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 30. U.K. Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 31. Italy Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 32. Russia Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 33. Nordic Countries Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 34. Benelux Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 35. By Region - Asia Remicade Biosimilar Revenue Market Share, 2018-2035
Figure 36. By Region - Asia Remicade Biosimilar Sales Market Share, 2018-2035
Figure 37. China Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 38. Japan Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 39. South Korea Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 40. Southeast Asia Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 41. India Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 42. By Country - South America Remicade Biosimilar Revenue Market Share, 2018-2035
Figure 43. By Country - South America Remicade Biosimilar Sales Market Share, 2018-2035
Figure 44. Brazil Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 45. Argentina Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 46. By Country - Middle East & Africa Remicade Biosimilar Revenue Market Share, 2018-2035
Figure 47. By Country - Middle East & Africa Remicade Biosimilar Sales Market Share, 2018-2035
Figure 48. Turkey Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 49. Israel Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 50. Saudi Arabia Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 51. UAE Remicade Biosimilar Revenue, (US$, Mn), 2018-2035
Figure 52. Global Remicade Biosimilar Production Capacity (L), 2018-2035
Figure 53. The Percentage of Production Remicade Biosimilar by Region, 2022 VS 2035
Figure 54. Remicade Biosimilar Industry Value Chain
Figure 55. Marketing Channels
